Kiora Pharmaceuticals Files Q1 2025 10-Q

Ticker: KPHMW · Form: 10-Q · Filed: May 9, 2025 · CIK: 1372514

Kiora Pharmaceuticals Inc 10-Q Filing Summary
FieldDetail
CompanyKiora Pharmaceuticals Inc (KPHMW)
Form Type10-Q
Filed DateMay 9, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, pharmaceuticals, financials

Related Tickers: KPRX

TL;DR

Kiora Pharma (KPRX) Q1 2025 10-Q filed. Check financials.

AI Summary

Kiora Pharmaceuticals Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Eyegate Pharmaceuticals Inc., is in the pharmaceutical preparations industry. Its principal executive offices are located at 332 Encinitas Boulevard, Suite 102, Encinitas, CA 92024.

Why It Matters

This filing provides investors with an update on Kiora Pharmaceuticals' financial performance and operational status for the first quarter of 2025.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Kiora Pharmaceuticals is subject to inherent risks related to drug development, regulatory approvals, and market competition.

Key Players & Entities

  • KIORA PHARMACEUTICALS INC (company) — Filer
  • EYEGATE PHARMACEUTICALS INC (company) — Former Company Name
  • 20250331 (date) — Period of Report
  • 20250509 (date) — Filing Date
  • 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 (address) — Business Address

FAQ

What was Kiora Pharmaceuticals' former name?

Kiora Pharmaceuticals Inc. was formerly known as Eyegate Pharmaceuticals Inc.

What is the SEC file number for Kiora Pharmaceuticals?

The SEC file number for Kiora Pharmaceuticals is 001-36672.

In which state was Kiora Pharmaceuticals incorporated?

Kiora Pharmaceuticals Inc. was incorporated in Delaware (DE).

What is the Standard Industrial Classification code for Kiora Pharmaceuticals?

The Standard Industrial Classification code for Kiora Pharmaceuticals is 2834 (Pharmaceutical Preparations).

What is the business address of Kiora Pharmaceuticals?

The business address of Kiora Pharmaceuticals is 332 Encinitas Boulevard, Suite 102, Encinitas, CA 92024.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding KIORA PHARMACEUTICALS INC (KPHMW).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.